Pill Identifier App

Milnacipran

In the US, Milnacipran (milnacipran systemic) is a member of the drug class serotonin-norepinephrine reuptake inhibitors and is used to treat Fibromyalgia and Reflex Sympathetic Dystrophy Syndrome.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AX17

CAS registry number (Chemical Abstracts Service)

0092623-85-3

Chemical Formula

C15-H22-N2-O

Molecular Weight

246

Therapeutic Category

Antidepressant: Selective serotonin and noradrenalin reuptake inhibitor (SSNRI)

Chemical Name

(±)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide

Foreign Names

  • Milnacipranum (Latin)
  • Milnacipran (German)
  • Milnacipran (French)
  • Milnaciprán (Spanish)

Generic Names

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)